Memorial Sloan Kettering Cancer Center, NY
Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College.
Dr. Tallman is a renowned expert in the management and development of new treatments for patients with both acute and chronic leukemia. Internationally recognized, he has been at the forefront of several key clinical trials that have led to new standards of care.
“There has never been a more exciting time in the field of malignant hematologic diseases,” said Dr. Tallman. “Memorial Sloan Kettering Cancer Center is well positioned to take advantage of the explosion of knowledge in addressing the molecular genetics of the acute and chronic leukemias. This new information, together with the myriad of new agents available, may well provide the foundation for continued new discoveries and the development of new, effective therapies.”
In addition to his significant contributions to clinical research, Dr. Tallman has held various leadership roles in the Eastern Cooperative Oncology Group, where he chairs the Leukemia Committee, the National Comprehensive Cancer Network, the International Bone Marrow Transplant Registry, the National Bone Marrow Program, and the Leukemia Research Foundation. In addition, he serves as one of 13 associate editors for the journal Blood.
Prior to his appointment at Memorial Sloan Kettering, Dr. Tallman served as a tenured Professor of Medicine at the Northwestern University Feinberg School of Medicine and Associate Chief of the Division of Hematology/Oncology at Northwestern University. Dr. Tallman received his MD degree from Chicago Medical School. After completing housestaff training in internal medicine at Northwestern University, Dr. Tallman held a fellowship in hematology and medical oncology at the Fred Hutchinson Cancer Research Center and the University of Washington.